triazolam has been researched along with Brain Vascular Disorders in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Triazolam-treated patients showed subsequent improvement on the tests, consistent with practice effects, whereas flurazepam recipients showed performance impairment during treatment." | 2.67 | Differential side effect profile of triazolam versus flurazepam in elderly patients undergoing rehabilitation therapy. ( Greenblatt, DJ; Proulx, SM; Woo, E, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woo, E | 1 |
| Proulx, SM | 1 |
| Greenblatt, DJ | 1 |
1 trial available for triazolam and Brain Vascular Disorders
| Article | Year |
|---|---|
Differential side effect profile of triazolam versus flurazepam in elderly patients undergoing rehabilitation therapy.
Topics: Aged; Cerebrovascular Disorders; Double-Blind Method; Evaluation Studies as Topic; Female; Flurazepa | 1991 |